Publications

Detailed Information

Glucosamine Treatment-mediated O-GlcNAc Modification of Paxillin Depends on Adhesion State of Rat Insulinoma INS-1 Cells

DC Field Value Language
dc.contributor.authorKwak, Tae Kyoung-
dc.contributor.authorKim, Hyeonjung-
dc.contributor.authorJung, Oisun-
dc.contributor.authorLee, Sin-Ae-
dc.contributor.authorKim, Hyun Jeong-
dc.contributor.authorKim, Sung-Hoon-
dc.contributor.authorLee, Jung Weon-
dc.contributor.authorPark, Ji-Min-
dc.contributor.authorKang, Minkyung-
dc.date.accessioned2012-07-03T04:20:47Z-
dc.date.available2012-07-03T04:20:47Z-
dc.date.issued2010-11-12-
dc.identifier.citationJOURNAL OF BIOLOGICAL CHEMISTRY; Vol.285 46; 36021-36031ko_KR
dc.identifier.issn0021-9258-
dc.identifier.urihttps://hdl.handle.net/10371/78208-
dc.description.abstractProtein-protein interactions and/or signaling activities at focal adhesions, where integrin-mediated adhesion to extracellular matrix occurs, are critical for the regulation of adhesion-dependent cellular functions. Although the phosphorylation and activities of focal adhesion molecules have been intensively studied, the effects of the O-GlcNAc modification of their Ser/Thr residues on cellular functions have been largely unexplored. We investigated the effects of O-GlcNAc modification on actin reorganization and morphology of rat insulinoma INS-1 cells after glucosamine (GlcN) treatment. We found that paxillin, a key adaptor molecule in focal adhesions, could be modified by O-GlcNAc in INS-1 cells treated with GlcN and in pancreatic islets from mice treated with streptozotocin. Ser-84/85 in human paxillin appeared to be modified by O-GlcNAc, which was inversely correlated to Ser-85 phosphorylation (Ser-83 in rat paxillin). Integrin-mediated adhesion signaling inhibited the GlcN treatment-enhanced O-GlcNAc modification of paxillin. Adherent INS-1 cells treated with GlcN showed restricted protrusions, whereas untreated cells showed active protrusions for multiple-elongated morphologies. Upon GlcN treatment, expression of a triple mutation (S83A/S84A/S85A) resulted in no further restriction of protrusions. Together these observations suggest that murine pancreatic beta cells may have restricted actin organization upon GlcN treatment by virtue of the O-GlcNAc modification of paxillin, which can be antagonized by a persistent cell adhesion process.ko_KR
dc.language.isoenko_KR
dc.publisherAMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INCko_KR
dc.titleGlucosamine Treatment-mediated O-GlcNAc Modification of Paxillin Depends on Adhesion State of Rat Insulinoma INS-1 Cellsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor곽태경-
dc.contributor.AlternativeAuthor김현정-
dc.contributor.AlternativeAuthor정외선-
dc.contributor.AlternativeAuthor이신애-
dc.contributor.AlternativeAuthor강민경-
dc.contributor.AlternativeAuthor김현정-
dc.contributor.AlternativeAuthor박지민-
dc.contributor.AlternativeAuthor김성훈-
dc.contributor.AlternativeAuthor이정원-
dc.identifier.doi10.1074/jbc.M110.129601-
dc.citation.journaltitleJOURNAL OF BIOLOGICAL CHEMISTRY-
dc.description.citedreferenceHarburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093-
dc.description.citedreferenceVicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564-
dc.description.citedreferenceKang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014-
dc.description.citedreferenceDehennaut V, 2008, BIOCHEM BIOPH RES CO, V369, P539, DOI 10.1016/j.bbrc.2008.02.063-
dc.description.citedreferenceLee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768-
dc.description.citedreferenceLock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001-
dc.description.citedreferenceZaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314-
dc.description.citedreferenceYang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470-
dc.description.citedreferenceZachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007-
dc.description.citedreferenceWerstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633-
dc.description.citedreferenceSchroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020-
dc.description.citedreferenceLin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200-
dc.description.citedreferenceLove D. C., 2005, SCI STKE, pre13, DOI DOI 10.1126/STKE.3122005RE13-
dc.description.citedreferenceIshibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006-
dc.description.citedreferenceBrown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004-
dc.description.citedreferenceZachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016-
dc.description.citedreferenceLee JW, 2004, MOL CELLS, V17, P188-
dc.description.citedreferenceD`Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje-
dc.description.citedreferenceHuang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081-
dc.description.citedreferenceWebb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094-
dc.description.citedreferenceThiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006-
dc.description.citedreferenceHuang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745-
dc.description.citedreferenceVosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8-
dc.description.citedreferenceCooksey RC, 2002, ANN NY ACAD SCI, V967, P102-
dc.description.citedreferenceSesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397-
dc.description.citedreferenceDu XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235-
dc.description.citedreferenceSchaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786-
dc.description.citedreferenceWells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714-
dc.description.citedreferenceTurner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659-
dc.description.citedreferenceCheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i-
dc.description.citedreferenceLiu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820-
dc.description.citedreferenceHanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016-
dc.description.citedreferenceCHOU TY, 1995, J BIOL CHEM, V270, P18961-
dc.description.citedreferenceKELLY WG, 1993, J BIOL CHEM, V268, P10416-
dc.description.citedreferenceBURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893-
dc.description.citedreferenceHYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S-
dc.description.citedreferenceTURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059-
dc.description.citedreferenceMCEVOY RC, 1984, J CLIN INVEST, V74, P715, DOI 10.1172/JCI111487-
dc.description.citedreferenceGEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127-
dc.description.citedreferenceKORNFELD R, 1967, J BIOL CHEM, V242, P3135-
dc.description.tc1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share